Adherence and Toxicity during the Treatment of Latent Tuberculous Infection in a Referral Center in Spain

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The screening and treatment of latent tuberculosis infection (LTBI) in countries with a low incidence of TB is a key strategy for the elimination of tuberculosis (TB). However, treatment can result in adverse events (AEs) and have poor adherence. This study aimed to describe treatment outcomes and AEs for LTBI patients at two departments in Vall d’Hebron University Hospital in Barcelona, Spain. A retrospective study was conducted on all persons treated for LTBI between January 2018 and December 2020. Variables collected included demographics, the reason for LTBI screening and treatment initiation, AEs related to treatment, and treatment outcome. Out of 261 persons who initiated LTBI treatment, 145 (55.6%) were men, with a median age of 42.1 years. The indications for LTBI screening were household contact of a TB case in 96 (36.8%) persons, immunosuppressive treatment in 84 (32.2%), and recently arrived migrants from a country with high TB incidence in 81 (31.0%). Sixty-three (24.1%) persons presented at least one AE during treatment, and seven (2.7%) required definitive discontinuation of treatment. In the multivariate analysis, AE development was more frequent in those who started LTBI treatment due to immunosuppression. Overall, 226 (86.6%) completed treatment successfully. We concluded that LTBI screening and treatment groups had different risks for adverse events and treatment outcomes. Persons receiving immunosuppressive treatment were at higher risk of developing AEs, and recently arrived immigrants from countries with a high incidence of TB had greater LTFU. A person-centered adherence and AE management plan is recommended.

References Powered by Scopus

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

1397Citations
N/AReaders
Get full text

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

764Citations
N/AReaders
Get full text

Guidelines for the treatment of latent tuberculosis infection: Recommendations from the national tuberculosis controllers association and CDC, 2020

321Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Factors Associated with Non-Adherence to Tuberculosis Preventive Treatment among Adult Contacts of Pulmonary Tuberculosis Cases with Latent Tuberculosis Infection in Catalonia, Spain, in 2019−2021

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Puyana Ortiz, J. D., Garcés Rodríguez, A. C., Aznar, M. L., Espinosa Pereiro, J., Sánchez-Montalvá, A., Martínez-Campreciós, J., … Molina, I. (2023). Adherence and Toxicity during the Treatment of Latent Tuberculous Infection in a Referral Center in Spain. Tropical Medicine and Infectious Disease, 8(7). https://doi.org/10.3390/tropicalmed8070373

Readers over time

‘23‘24‘2502468

Readers' Seniority

Tooltip

Lecturer / Post doc 1

50%

PhD / Post grad / Masters / Doc 1

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

67%

Nursing and Health Professions 1

33%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free
0